drugset / Trial / NCT03433144

The Effects of Tranexamic Acid on Blood Loss During Orthognathic Surgery

NCT03433144 ↗

Phase 4 Withdrawn Nick Emanuele
RandomizedParallel-groupSingle-blindTreatment

Summary

This study seeks to answer the question: Does a single pre-operative dose of tranexamic acid have a statistically significant reduction in blood loss during orthognathic surgery? If it does, this drug may begin to be used routinely during orthognathic surgery to reduce blood loss in our patients.

Timeline

Start
2018-06-01
Primary completion
2019-02-01
Completion
2020-07-06

Outcome

Outcome not reported

Stopped (Business): “Lack of funding”

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 10 mg/kg Intravenous

Indications

No indication recorded.